Relations of changes in coronary disease rates and changes in risk factor levels: Methodological issues and a practical example

American Journal of Epidemiology

Volumn 143, Issue 10, 1996, Pages 1025-1034

  Dobson, Annette ^a,h   Filipiak, Birgit ^b   Kuulasmaa, Kari ^c   Beaglehole, Robert ^d   Stewart, Alistair ^d   Hobbs, Michael ^e   Parsons, Richard ^e   Keil, Ulrich ^b,f   Greiser, Eberhard ^g   Korhonen, Heikki ^c   Tuomilehto, Jaakko ^c,h  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

^h UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

coronary disease; measurement error; mortality; proportional hazards models; risk factors

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY RISK; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; WORLD HEALTH ORGANIZATION;

EID: 15844397758     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008666     Document Type: Article

References (23)

1. WHO MONICA Project (prepared by Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al.). Myocardial infarction and coronary deaths in the World Health Organization MONICA Project-registration procedures, event rates and case fatality rates in 38 populations from 21 countries in 4 continents. Circulation 1994;90:583-612.
2. Stieber J, Hense HW, Döling A, et al. Kardiovaskuläres Risikofaktorenprofil Verlaufsdaten aus der MONICA-Studienregion Augsburg (1984/85 vs. 1989/90). (In German) Münch Med Wschr 1990;133:370-5.
3. Herman B, Greiser E, Helmert U, et al. Prevalence of cardiovascular risk factors in the city of Bremen - the 1984 Bremen baseline health survey of the German Cardiovascular Prevention Study. Soz Praeventivmed 1987;32:31-8.
4. Vartiainen E, Korhonen HJ, Pietinen P, et al. Fifteen-year trends in coronary risk factors in Finland, with special reference to North Karelia. Int J Epidemiol 1991:20:651-62.
5. Auckland, Newcastle, and Perth MONICA Centres. Risk factor levels and mortality of ischaemic heart disease in three Australasian centres. Med J Aust 1988;148:61-5.
6. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease: overall findings and differences by age for 316099 white men. Arch Intern Med 1992;152:56-64.
7. Jackson R, Beaglehole R, Lay Yee R, et al. Trends in cardiovascular risk factors in Auckland, 1982-1987. NZ Med J 1990;103:363-5.
8. Dobson AJ. Proportional hazards models for average data for groups. Stat Med 1988:7:613-18.
9. Fuller WA. Measurement error models. New York: Wiley, 1987.
10. Francis B, Green M, Payne C, et al, eds. The GLIM system: release 4 manual. Oxford: Clarendon Press, 1993.
11. Sprafka JM, Burke GL, Folsom AR, et al. Continued decline in cardiovascular disease risk factors: results of the Minnesota Heart Survey, 1980-82 and 1985-87. Am J Epidemiol 1990; 132:489-500.
12. Kleinman JC, De Gruttola VG, Cohen BB, et al. Regional and urban-suburban differentials in coronary heart disease mortality and risk factor prevalence. J Chronic Dis 1981;34:11-19.
13. Rodes A, Sans S, Balana L, et al. Recruitment methods and differences in early, late and non-respondents in the first MONICA - Catalonia population survey. Proceedings of the 3rd MONICA Congress. Rev Epidémiol Santé Publique 1990; 38:447-53.
14. Rosenbaum PR, Rubin DB. Difficulties with regression analysis of age-adjusted rates. Biometrics 1984;40:437-43.
15. Breslow NE, Day NE. Statistical methods in cancer research. Vol 2. The design and analysis of cohort studies. Lyon: International Agency for Research on Cancer, 1987.
16. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke and coronary heart disease. Part 2. Short term reductions in blood pressure: overview of randomised drug trials in their epidemiologic context. Lancet 1990;335:827-38.
17. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984;251:365-74.
18. Manson JE, Tosteson H, Ridker PM, et at. The primary prevention of myocardial infarction. N Engl J Med 1992;326: 1406-16.
19. Feinleib M, Leaverton PE. Ecologic fallacies in epidemiology. In: Leaverton PE, Mass L, eds. Health information systems. New York: Kreiger, 1984:33-61.
20. Sigfusson N, Sigvaldason H, Steingrimsdottir L, et al. Decline in ischaemic heart disease in Iceland and change in risk factor levels. Br Med J 1991;302:1371-5.
21. Kaplan GA, Cohn BA, Cohen RD, et al. The decline in ischaemic heart disease mortality: prospective evidence from the Alameda County study. Am J Epidemiol 1988;127: 1131-42.
22. Keil U, Filipiak B, Döring A, et al. Monitoring trends and determinants in cardiovascular disease in Germany: results of the MONICA Project Augsburg, 1985-1990. In: Proceedings of the 1992 International Symposium on Public Health Surveillance. MMWR 1992;41(suppl):171-9.
23. Vartiainen E, Puska P, Pekkanen J, et al. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. Br J Med 1994;309:23-7.